Ftse Mib
33.766,29
-0,06%
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
1,03%
Bitcoin
96.590,58
-0,63%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Praxis Precision Medicines Inc (PRAX) Praxis Precision Medicines Inc (PRAX) Notizie

Praxis Precision Medicines Inc

PRAX
76,15
3,31 (4,54%)
21 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/11/202403:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202403:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202403:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202403:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202423:50EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202420:32EDGAR2Form 144 - Report of proposed sale of securities
14/11/202419:45EDGAR2Form 144 - Report of proposed sale of securities
08/11/202420:17EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
06/11/202413:59EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202413:57EDGAR2Form 8-K - Current report
15/10/202414:00EDGAR2Form 8-K - Current report
26/9/202414:00GLOBEPraxis Precision Medicines presents on ulixacaltamide..
03/9/202414:15EDGAR2Form 8-K - Current report
13/8/202413:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/8/202413:20EDGAR2Form 8-K - Current report
01/8/202403:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202403:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202403:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/6/202422:56EDGAR2Form S-8 POS - Securities to be offered to employees in..
07/6/202400:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202400:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202423:09EDGAR2Form 8-K - Current report
20/5/202414:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/5/202414:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202414:18EDGAR2Form 8-K - Current report
12/4/202414:00GLOBEPraxis Precision Medicines to Present on Ulixacaltamide at..
05/3/202415:08EDGAR2Form S-3 - Registration statement under Securities Act of..
05/3/202413:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/3/202413:13EDGAR2Form 8-K - Current report
05/3/202413:12EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/2/202402:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202416:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202401:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202422:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
17/1/202422:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202422:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202423:23EDGAR2Form 8-K - Current report
12/1/202423:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/1/202412:01EDGAR2Form 8-K - Current report
10/1/202423:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/1/202422:19GLOBEPraxis Precision Medicines, Inc. Announces Proposed Public..
10/1/202422:10EDGAR2Form 8-K - Current report
10/1/202403:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202403:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202403:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 71,25 Min: 71,25 Max: 79,40
Chiusura: 72,84

La tua Cronologia

NASDAQ
PRAX
Praxis Precision Medicines
BIT
NSCIT5354658
Intesa Sanpaolo
NASDAQ
CFTOX
Ci Portfolio Series Grow...
NASDAQ
CDEEX
Ci G520i 2036 Q2 Fund Cl...
AQSE
RCDO.GB
Ricardo
BIT
ABT
Abitare In
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network